NEW YORK (GenomeWeb News) – The Association for Molecular Pathology today announced that it has submitted to an American Medical Association panel its proposal for CPT codes for sequencing-based assays.

The proposal was developed by AMP's Economic Affairs Committee — which develops and advocates for sound economic policies that "promote the provision of high quality molecular pathology services" — and was submitted to AMA's CPT Editorial Panel.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.